CytoMed Therapeutics Limited Increase Decrease Through Exercise Of Warrants Equity
CytoMed Therapeutics Limited (GDTC) reported Increase Decrease Through Exercise Of Warrants Equity of SGD 73.93 thousand for the 12-month period ending 2023-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity · last filed 2026-03-31
| Period end | Increase Decrease Through Exercise Of Warrants Equity 12 month | Increase Decrease Through Exercise Of Warrants Equity 12 month as first filed |
|---|---|---|
| 2023-12-31 | 73.93K SGD 20-F · filed 2026-03-31 | -73.93K SGD 20-F · filed 2024-04-22 |